ArticleClinical cancer research : an official journal of the American Association for Cancer Research2025

A Tumor-Naïve ctDNA Assay Detects Minimal Residual Disease in Resected Stage II or III Colorectal Cancer and Predicts Recurrence: Subset Analysis from the GALAXY Study in CIRCULATE-Japan.

Yoshiaki Nakamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.